Citizens Business Bank Abbott Laboratories Transaction History

Citizens Business Bank

  • $476 Million
  • Q3 2024

A detailed history of Citizens Business Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Citizens Business Bank holds 2,533 shares of ABT stock, worth $285,266. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,533
Previous 2,533 -0.0%
Holding current value
$285,266
Previous $263,000 9.51%
% of portfolio
0.06%
Previous 0.06%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024
SELL
$100.07 - $118.13 $2,201 - $2,598
-22 Reduced 0.87%
2,511 $286,000
Q2 2024

Aug 02, 2024
SELL
$100.73 - $112.44 $48,148 - $53,746
-478 Reduced 15.88%
2,533 $263,000
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $7,264 - $8,550
-75 Reduced 2.43%
3,011 $304,000
Q3 2022

Nov 03, 2022
BUY
$96.76 - $112.03 $298,601 - $345,724
3,086 New
3,086 $299,000
Q1 2022

Nov 18, 2022
SELL
$114.02 - $139.04 $17,103 - $20,856
-150 Reduced 4.56%
3,136 $371,000
Q4 2021

Nov 18, 2022
BUY
$115.53 - $141.46 $5,776 - $7,073
50 Added 1.55%
3,286 $463,000
Q3 2021

Nov 18, 2022
SELL
$116.66 - $129.06 $11,666 - $12,906
-100 Reduced 3.0%
3,236 $382,000
Q2 2021

Nov 18, 2022
SELL
$105.79 - $124.53 $21,158 - $24,906
-200 Reduced 5.66%
3,336 $387,000
Q1 2021

Nov 18, 2022
SELL
$108.84 - $128.23 $10,884 - $12,822
-100 Reduced 2.75%
3,536 $424,000
Q3 2020

Nov 18, 2022
SELL
$91.64 - $111.29 $18,328 - $22,258
-200 Reduced 5.21%
3,636 $396,000
Q1 2020

Nov 18, 2022
SELL
$62.82 - $91.86 $35,116 - $51,349
-559 Reduced 12.72%
3,836 $303,000
Q4 2019

Nov 18, 2022
SELL
$78.51 - $87.4 $103,162 - $114,843
-1,314 Reduced 23.02%
4,395 $382,000
Q3 2019

Nov 18, 2022
SELL
$81.84 - $88.74 $53,114 - $57,592
-649 Reduced 10.21%
5,709 $478,000
Q2 2019

Nov 18, 2022
SELL
$72.88 - $85.0 $494,199 - $576,385
-6,781 Reduced 51.61%
6,358 $534,000
Q1 2019

Nov 18, 2022
SELL
$66.22 - $80.06 $24,368 - $29,462
-368 Reduced 2.72%
13,139 $1.05 Million
Q4 2018

Nov 18, 2022
SELL
$65.56 - $74.27 $138,528 - $156,932
-2,113 Reduced 13.53%
13,507 $977,000
Q3 2018

Nov 18, 2022
SELL
$60.81 - $73.36 $169,720 - $204,747
-2,791 Reduced 15.16%
15,620 $1.15 Million
Q2 2018

Nov 18, 2022
SELL
$57.57 - $63.54 $143,925 - $158,850
-2,500 Reduced 11.96%
18,411 $1.12 Million
Q1 2018

Nov 18, 2022
SELL
$56.27 - $63.62 $433,279 - $489,874
-7,700 Reduced 26.91%
20,911 $1.25 Million
Q3 2017

Nov 18, 2022
SELL
$48.06 - $53.64 $235,494 - $262,836
-4,900 Reduced 14.62%
28,611 $1.53 Million
Q2 2017

Nov 18, 2022
BUY
N/A
30,425 Added 985.9%
33,511 $1.63 Million
Q1 2017

Nov 18, 2022
SELL
N/A
-32,100 Reduced 44.03%
40,811 $1.81 Million
Q4 2016

Nov 18, 2022
BUY
N/A
36,992 Added 102.99%
72,911 $2.8 Million
Q3 2016

Nov 18, 2022
BUY
N/A
1,458 Added 4.23%
35,919 $1.52 Million
Q2 2016

Nov 18, 2022
BUY
N/A
1,992 Added 6.14%
34,461 $1.36 Million
Q1 2016

Nov 18, 2022
BUY
N/A
32,469 New
32,469 $1.36 Million
Q4 2015

Nov 18, 2022
SELL
N/A
-6,919 Closed
0 $0
Q3 2015

Nov 18, 2022
SELL
N/A
-60 Reduced 0.86%
6,919 $278,000
Q2 2015

Nov 18, 2022
SELL
N/A
-90 Reduced 1.27%
6,979 $342,000
Q1 2015

Nov 18, 2022
SELL
N/A
-1,592 Reduced 18.38%
7,069 $328,000
Q4 2014

Nov 18, 2022
SELL
N/A
-200 Reduced 2.26%
8,661 $390,000
Q3 2014

Nov 18, 2022
SELL
N/A
-45 Reduced 0.51%
8,861 $369,000
Q2 2014

Nov 18, 2022
BUY
N/A
200 Added 2.3%
8,906 $364,000
Q2 2013

Nov 18, 2022
BUY
N/A
1,004 Added 13.04%
8,706 $304,000
Q1 2013

Nov 18, 2022
SELL
N/A
-14,756 Reduced 65.7%
7,702 $272,000
Q4 2012

Nov 18, 2022
BUY
N/A
19,372
22,458 $1.47 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Citizens Business Bank Portfolio

Follow Citizens Business Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email